Cambridge Healthcare Research
Frederick has over 15 years of experience in pharmaceutical business development, merger and acquisition and preclinical research. His areas of focus include oncology, ophthalmology, and cell and gene therapies.
Currently Frederick lives in Shanghai while serving as a biotech investment professional. Prior to that, he held multiple leadership positions in biotechs and biopharmas across Asia, including SanBio (Tokyo), CStone (Shanghai), Santen (Singapore) and HUTCHMED (Shanghai).
Frederick holds BSc and PhD in Biochemistry from the National University of Singapore, and MSc in Management from ESSEC Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cambridge Healthcare Research
2 followers
The team at Cambridge Healthcare Research (CHR) provides strategic decision support and action planning to a wide range of stakeholders in the life-science and healthcare space. Working closely with our clients, CHR translates evolving treatment algorithms, patient pathways and novel technologies into tailored landscape analyses, commercial opportunity assessments, market models and into product sales forecasts. Our evaluation of market dynamics, combined with a targeted understanding of key trends in the prescriber, regulator, and payer environments, equips our clients to make the best decisions from an optimally informed position.